Clinical trial
Effect of Anti CD20 in Pemphigus Desease
NCT00213512 · University Hospital, Rouen, Other · Completed
Key facts
| NCT number | NCT00213512 |
|---|---|
| Title | Effect of Anti CD20 in Pemphigus Desease |
| Official title | Traitment of Patients Presenting Pemphigus With Anti CD20 (Mabthera). |
| Lead sponsor | University Hospital, Rouen, Other |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Pemphigus |
| Intervention type | Drug |
| Interventions | Mabthera |
| Enrollment | 22 |
| Start date | Jun 1, 2003 |
| Primary completion | Jun 1, 2006 |
| Completion | Oct 1, 2008 |
| First posted | Sep 21, 2005 |
| Last update posted | Jun 18, 2013 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: